Navigation Links
Smith & Nephew Orthopaedic Reconstruction Global Management Team Announced
Date:2/29/2008

was Vice President of Global Marketing for the Memphis-based Reconstructive division. He joined the company in June 2005 and has nearly 20 years of medical device experience including marketing leadership positions at Guidant and DePuy Orthopaedics. He holds a bachelor's degree in engineering from the University of Vermont and an MBA from Boston University.

Steve Couldwell

Couldwell, 47, was named president of Orthopaedics Europe in September 2005 and has been with Smith & Nephew for 18 years. Previously, Couldwell was the innovation and business development VP for the Advanced Wound Management global business unit. In this role, he was responsible for delivering high value innovation from the R&D pipeline; driving business development and facilitating future planning efforts. Prior to this role he was VP Global Sales and Marketing, also for Wound. Couldwell began his Smith & Nephew career in sales management and has also held leadership positions in human resources for Europe, distribution and commercial operations. He held sales and marketing posts with Warner Lambert (Pfizer) prior to joining Smith & Nephew. Couldwell holds a bachelor's degree in business studies from the University of Huddersfield, North Yorkshire.

Andrew Holman

Holman, 40, was appointed president of the Americas in September 2007, where he oversees sales, marketing, development, logistics and commercial operations in the U.S., North and South America. Holman joined Smith & Nephew in September 2005 as vice president, U.S. Reconstruction sales where under his leadership top line growth excelled. Holman has nearly 15 years of medical device experience, having previously held positions at Codman and Shurtleff, Inc., a subsidiary of Johnson & Johnson, Inc. and Boston Scientific. Holman holds a bachelor's degree in psychology and business administration from Rollins College.

Joseph DeVivo

DeVivo, 41, joined Smith & Nephew as president of the company's Orthop
'/>"/>

SOURCE Smith & Nephew, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Celebrity Cook Paula Deen and Husband Michael Groover Bring Smithfield Foods Helping Hungry Homes(TM) Tour To Feed New Orleans Families
2. EUSA Pharma Out-Licenses Preclinical-Stage Human Antibody to GlaxoSmithKline for up to $44 Million Plus Royalties
3. Celebrity Cook Paula Deen and Husband Michael Groover Bring Smithfield Foods Helping Hungry Homes(TM) Tour to L.A.
4. Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program
5. Senator Sam Brownback and Rep. Chris Smith to Speak at Blogs for Life
6. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Security Capital Assurance Ltd.
7. AUDIO from Medialink and GlaxoSmithKline: Get Ready to Get Moving to a New You in the New Year
8. Audio from Medialink and GlaxoSmithKline: Cleaning House ... Overhaul Your Fridge and Pantry to Lose Weight
9. VIDEO from Medialink and GlaxoSmithKline: Really Think You Can Lose 30 Pounds in 30 Days?
10. AUDIO from Medialink and GlaxoSmithKline: Setting Realistic Goals for a New You in the New Year
11. AUDIO from Medialink and GlaxoSmithKline: Shifting Your Focus for a Lighter, Healthier New Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2008)... ORSupply.com expands its selection o... to include full diagnostic product lines from Lit...ille, KY (Vocus) December 3, 2008 -- Littmann and ...ORSupply.com, the Internet’s largest marketp... adding Littman and Heine stethoscopes to its onli...
(Date:12/2/2008)...reast-specific gamma imaging (BSGI) is effective i... or by clinical exam, according to a study present... Society of North America (RSNA). , "BSGI can id...nvasive lobular carcinoma," said lead author Rache...or of the Breast Imaging and Interventional Center...
(Date:12/2/2008).... 3 Minimally invasive,...thod for removal of self-inflicted,foreign object..."self-,embedding disorder," or self-injury and se...s. The findings will be presented today at the ann...America (RSNA). , "Radiologists are in a un...
(Date:12/2/2008)...ANCISCO, Calif., Dec. 1 diaDexus, ...roval for the automated format of the,PLAC Test f...est, capable of,running on a wide range of clinic....S. Food & Drug Administration (FDA) in Decemb...nt of the CE Marked PLAC Test to Europe. , ...
Breaking Medicine News(10 mins):Health News:Littmann and Heine Stethoscopes Now Available from ORSupply.com 2Health News:Littmann and Heine Stethoscopes Now Available from ORSupply.com 3Health News:New breast imaging technology targets hard-to-detect cancers 2Health News:Radiologists Diagnose and Treat Self-Embedding Disorder in Teens 2Health News:Radiologists Diagnose and Treat Self-Embedding Disorder in Teens 3Health News:diaDexus Receives CE Mark Certification for the PLAC(R) Test 2
...nsurance plans show wide variations among differen...premium dollar. // -Employees in the smallest fir... insurance premiums than those in the largest firm...--the percentage of total medical expenses paid by...
...egulatory body is set up by the Indian information...ter the theft of data, by 3 employees of a BPO fir... in the IT industry. The move is to bolster overse... of instances have stirred the IT sector to set up...
...ptive pill, Dianette also used to treat acne, has ...rities after concerns were expressed about its lin...ntraceptive that was licensed as a hormone treatme...r review when over 100 women said they suffered de...
...n Ilhan tenderly kissed his 2-year-old daughter, J... as he kissed Jaida, he noticed that her face bega... whether it was caused by something she ate or som...t it was me,' he recalled. 'I ate some peanuts tha...
Other Medicine News:Health News:Health Insurance Plans Varies among States 2Health News:Health Insurance Plans Varies among States 3Health News:Allergic to Kisses? 2
(Date:12/1/2008)...PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc...ncet , one of the world,s leading medical journals...n regulator, experimental compound tasimelteon (VE... entitled "Melatonin agonist tasimelteon (VEC-162)...o randomised controlled multicentre trials." Resul...
(Date:12/1/2008)...hatasia Treated With ENB-0040 at Children,s Hospit...MONTREAL, Dec. 1 Enobia Pharma, an...loping novel therapeutics for serious bone disorde...in its clinical program for hypophosphatasia was d...herapy (ERT) with ENB-0040 for the treatment of th...
(Date:12/1/2008)...December 1 Following a,...t to procure an MVA-based,third generation small...,Canada, on behalf of the Canadian Department of N...an Nordic for the delivery of IMVAMUNE(R). , ...R) as part of the,country,s bio-preparedness prog...
(Date:11/30/2008).... 1 Older adults who ex...w and a greater number of small blood vessels in t... the annual meeting of the Radiological Society of...ucted at the University of North Carolina ( UNC)...ns of older adults who exercise to brain scans of ...
Breaking Medicine Technology:Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3Thyroid Hormone Could One Day Treat Osteoporosis 13954 1Thyroid Hormone Could One Day Treat Osteoporosis 13954 2Thyroid Hormone Could One Day Treat Osteoporosis 13954 3Alarming growth in expected CO2 emissions in China finds UC analysis 2451 1Alarming growth in expected CO2 emissions in China finds UC analysis 2451 2Alarming growth in expected CO2 emissions in China finds UC analysis 2451 3GFX 3A Wrinkle Killer or Botox 28R 29 Hit Man 3F 13950 1GFX 3A Wrinkle Killer or Botox 28R 29 Hit Man 3F 13950 2GFX 3A Wrinkle Killer or Botox 28R 29 Hit Man 3F 13950 3Injection of human umbilical cord blood helps the aging brain 13948 1Injection of human umbilical cord blood helps the aging brain 13948 2
...ay 29, 2007 - Gilead,Sciences, Inc. (Nasdaq:GILD) ...007) study of aztreonam lysine for inhalation for,...who have,pulmonary Pseudomonas aeruginosa (P. aeru...e at Day 28 from baseline in respiratory,symptoms,...Revised,(CFQ-R), a patient-reported outcome (PRO) ...
...for Organ Transplantation, HORSHOLM, Denmark, May ...a announces positive Phase I clinical results for,... Heads into US,Phase II clinical trials for organ ...:LCP) announces positive results,from its Phase I ..., once-daily tacrolimus tablet. , A series of Phas...
Other Medicine Technology:Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 2Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 3Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 4Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 5LifeCycle Pharma Announces Positive Phase I Clinical Results for,its Transplantation Product Candidate, LCP-Tacro 2LifeCycle Pharma Announces Positive Phase I Clinical Results for,its Transplantation Product Candidate, LCP-Tacro 3
VERSASTEP™ Reposable Short Single-Use For use with VERSASTEP™ Short Reusable Cannula, Dilator.
VersaStep™ Reposable Sterilization Trays.
VERSASTEP™ Plus Long Instrument for applications in laparoscopic procedures., ,The VERSASTEP™ Plus Long Instrument with 150mm Working Length is a unique endoscopic entry device that has
...ade; Blunt Tip Trocar consists of a blunt obturato... , ,The valve body assembly contains an internal ... instruments are inserted or withdrawn. The Autosu...verters to allow insertion of instruments of diffe...
Medicine Products: